[GAMUDA] QoQ TTM Result on 31-Jul-2012 [#4]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
27-Sep-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2012
Quarter
31-Jul-2012 [#4]
Profit Trend
QoQ- 2.68%
YoY- 28.65%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
TTM Result
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
Revenue 2,564,319 2,629,125 2,898,272 3,087,003 2,927,795 2,843,136 2,681,000 -2.92%
PBT 637,540 733,228 734,291 728,210 702,599 664,940 601,994 3.90%
Tax -115,989 -139,485 -154,681 -162,219 -150,910 -138,026 -125,415 -5.08%
NP 521,551 593,743 579,610 565,991 551,689 526,914 476,579 6.20%
-
NP to SH 514,222 580,841 560,424 547,305 533,026 511,646 469,198 6.30%
-
Tax Rate 18.19% 19.02% 21.07% 22.28% 21.48% 20.76% 20.83% -
Total Cost 2,042,768 2,035,382 2,318,662 2,521,012 2,376,106 2,316,222 2,204,421 -4.95%
-
Net Worth 4,406,513 4,235,195 4,182,122 4,052,884 3,984,736 3,825,379 3,818,879 10.02%
Dividend
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
Div 251,950 249,362 249,362 248,378 248,378 247,276 247,276 1.25%
Div Payout % 49.00% 42.93% 44.50% 45.38% 46.60% 48.33% 52.70% -
Equity
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
Net Worth 4,406,513 4,235,195 4,182,122 4,052,884 3,984,736 3,825,379 3,818,879 10.02%
NOSH 2,118,516 2,086,303 2,080,658 2,078,402 2,075,383 2,067,772 2,064,259 1.74%
Ratio Analysis
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
NP Margin 20.34% 22.58% 20.00% 18.33% 18.84% 18.53% 17.78% -
ROE 11.67% 13.71% 13.40% 13.50% 13.38% 13.38% 12.29% -
Per Share
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
RPS 121.04 126.02 139.30 148.53 141.07 137.50 129.88 -4.59%
EPS 24.27 27.84 26.93 26.33 25.68 24.74 22.73 4.47%
DPS 12.00 12.00 12.00 12.00 12.00 12.00 12.00 0.00%
NAPS 2.08 2.03 2.01 1.95 1.92 1.85 1.85 8.13%
Adjusted Per Share Value based on latest NOSH - 2,078,402
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
RPS 92.55 94.89 104.60 111.42 105.67 102.61 96.76 -2.92%
EPS 18.56 20.96 20.23 19.75 19.24 18.47 16.93 6.32%
DPS 9.09 9.00 9.00 8.96 8.96 8.92 8.92 1.26%
NAPS 1.5904 1.5286 1.5094 1.4628 1.4382 1.3807 1.3783 10.02%
Price Multiplier on Financial Quarter End Date
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
Date 30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 -
Price 4.07 3.72 3.61 3.51 3.56 3.70 3.40 -
P/RPS 3.36 2.95 2.59 2.36 2.52 2.69 2.62 18.05%
P/EPS 16.77 13.36 13.40 13.33 13.86 14.95 14.96 7.91%
EY 5.96 7.48 7.46 7.50 7.21 6.69 6.69 -7.42%
DY 2.95 3.23 3.32 3.42 3.37 3.24 3.53 -11.28%
P/NAPS 1.96 1.83 1.80 1.80 1.85 2.00 1.84 4.30%
Price Multiplier on Announcement Date
30/04/13 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 CAGR
Date 27/06/13 28/03/13 13/12/12 27/09/12 28/06/12 28/03/12 16/12/11 -
Price 4.56 4.13 3.64 3.40 3.46 3.60 3.00 -
P/RPS 3.77 3.28 2.61 2.29 2.45 2.62 2.31 38.65%
P/EPS 18.79 14.83 13.51 12.91 13.47 14.55 13.20 26.56%
EY 5.32 6.74 7.40 7.74 7.42 6.87 7.58 -21.04%
DY 2.63 2.91 3.30 3.53 3.47 3.33 4.00 -24.40%
P/NAPS 2.19 2.03 1.81 1.74 1.80 1.95 1.62 22.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment